ConductScience.org, home

Paper27353166

In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.

Zhang Y and 2 others. J Antibiot (Tokyo), 2016. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline. Papers, record 27353166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27353166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.
PubMed
Journal
J Antibiot (Tokyo)
PubMed
Year
2016
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2019-12-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYunliang
2Lin XXiaoyan
3Bush KKaren

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
EnterobacteriaceaeMajor topic
TetracyclinesMajor topic
beta-LactamasesMajor topic
Carbapenems
Drug Resistance, Multiple, Bacterial
Microbial Sensitivity Tests
Polymerase Chain Reaction
beta-Lactam Resistance

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126263298New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections.Curr Opin Crit Care2015https://conductscience.org/library/papers/26263298PubMed
219687234Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19687234PubMed
322354310Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22354310PubMed
425691636Eravacycline (TP-434) is efficacious in animal models of infection.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25691636PubMed
523219246Detection systems for carbapenemase gene identification should include the SME serine carbapenemase.Int J Antimicrob Agents2013https://conductscience.org/library/papers/23219246PubMed
624463280The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.Clin Infect Dis2014https://conductscience.org/library/papers/24463280PubMed
717005839SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/17005839PubMed
816048978First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16048978PubMed
926059625Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA.Future Microbiol2015https://conductscience.org/library/papers/26059625PubMed
1024247134
Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups.
Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24247134PubMed
1125534744Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25534744PubMed
1221474585Combating antimicrobial resistance: policy recommendations to save lives.Clin Infect Dis2011https://conductscience.org/library/papers/21474585PubMed
1321398074Multiplex PCR for detection of acquired carbapenemase genes.Diagn Microbiol Infect Dis2011https://conductscience.org/library/papers/21398074PubMed
1425277839Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising?Curr Opin Pharmacol2014https://conductscience.org/library/papers/25277839PubMed
1524381080Notes from the Field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013.MMWR Morb Mortal Wkly Rep2014https://conductscience.org/library/papers/24381080PubMed
1621840669Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit.Diagn Microbiol Infect Dis2011https://conductscience.org/library/papers/21840669PubMed
1724602953Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae.Infect Control Hosp Epidemiol2014https://conductscience.org/library/papers/24602953PubMed
1811257029Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11257029PubMed
1911036019SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/11036019PubMed
2025534728In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25534728PubMed

See all 27 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42827677Evaluation of eravacycline susceptibility testing by MIC test strip and disk diffusion against broth microdilution in carbapenem-resistant Enterobacterales.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42827677PubMed
42192725Beyond β-Lactams: Defining the Role of Eravacycline in Multidrug-Resistant and Metallo-β-Lactamase-Producing Infections.Antibiotics (Basel)2026https://conductscience.org/library/papers/42192725PubMed
41471170Resistance of Gram-Negative Bacteria to Eravacycline: A Systematic Review of Data from In Vitro Studies.Pathogens2025https://conductscience.org/library/papers/41471170PubMed
41301604Use of Aztreonam-Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae.Antibiotics (Basel)2025https://conductscience.org/library/papers/41301604PubMed
41269026Evaluating eravacycline's efficacy against pediatric carbapenem-resistant Klebsiella pneumoniae in China: a 6-year study.Microbiol Spectr2026https://conductscience.org/library/papers/41269026PubMed
40329078In vitro synergistic effect and mutant prevention concentration of eravacycline alone or in combination with various antibiotics against OXA-48 producing enterobacterales.J Antibiot (Tokyo)2025https://conductscience.org/library/papers/40329078PubMed
39624714In vitro activities of eravacycline against clinical bacterial isolates: a multicenter study in Guangdong, China.Front Microbiol2024https://conductscience.org/library/papers/39624714PubMed
37509424In Vitro Activity of Eravacycline against Carbapenemase-Producing Gram-Negative Bacilli Clinical Isolates in Central Poland.Biomedicines2023https://conductscience.org/library/papers/37509424PubMed
36877080Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of Enterobacteriaceae and Enterococci.J Clin Microbiol2023https://conductscience.org/library/papers/36877080PubMed
36421250Update on the Management of Surgical Site Infections.Antibiotics (Basel)2022https://conductscience.org/library/papers/36421250PubMed
36187949Drug development concerning metallo-β-lactamases in gram-negative bacteria.Front Microbiol2022https://conductscience.org/library/papers/36187949PubMed
34854060
Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
Infection2022https://conductscience.org/library/papers/34854060PubMed
34169446Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions.Eur J Clin Microbiol Infect Dis2021https://conductscience.org/library/papers/34169446PubMed
32987821Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study.Antibiotics (Basel)2020https://conductscience.org/library/papers/32987821PubMed
32152509Critical analysis of antibacterial agents in clinical development.Nat Rev Microbiol2020https://conductscience.org/library/papers/32152509PubMed
32102899Epidemiology of β-Lactamase-Producing Pathogens.Clin Microbiol Rev2020https://conductscience.org/library/papers/32102899PubMed
31843999In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/31843999PubMed
31388008The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase.Nat Commun2019https://conductscience.org/library/papers/31388008PubMed
31086308Antimicrobial resistance in nephrology.Nat Rev Nephrol2019https://conductscience.org/library/papers/31086308PubMed
30761114Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options.Front Microbiol2019https://conductscience.org/library/papers/30761114PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27353166

GET https://conductscience.org/api/papers/v1/27353166/references?page=2